In the BioHarmony Drug Report Database
Levonordefrin
Carbocaine W/ Neo-cobefrin (levonordefrin) is a small molecule pharmaceutical. Levonordefrin was first approved as Carbocaine W/ Neo-cobefrin on 1982-01-01. It is used to treat oral ulcer and toothache in the USA. It is known to target alpha-1D adrenergic receptor.
Trade Name
|
Carbocaine W/ Neo-cobefrin |
|---|---|
Common Name
|
levonordefrin |
ChEMBL ID
|
CHEMBL677 |
Indication
|
oral ulcer, toothache |
Drug Class
|
Image (chem structure or protein)